ORCHIDPHAR

Orchid Pharma Limited has informed the Exchange regarding a press release dated September 21, 2018, titled "Approval of Resolution Plan by NCLT, Chennai".

Orchid Pharma Limited has informed the Exchange regarding a press release dated May 26, 2017, titled "Press release issued in connection with Audited Financial Results of the Company for the year ended March 31, 2017".

Orchid Pharma Limited has informed the Exchange regarding a press release dated April 18, 2017, titled "Establishment Inspection Report from USFDA".

Orchid Pharma Limited has informed the Exchange regarding a press release dated February 07, 2017, titled "Press release issued in connection with Unaudited Financial Results of the Company for the Quarter ended December 31, 2016".

Orchid Pharma Limited has informed the Exchange regarding a press release dated November 09, 2016

Orchid Pharma Limited has informed the Exchange regarding Press Release dated August 13, 2016 title "Orchid Pharma registers turnover of Rs. 190.9 crore in Q1 FY17, EBITDA of Rs. 22.3 crore."

Orchid Pharma Limited has informed the Exchange regarding a press release dated May 27, 2016 titled "Orchid Pharma registers turnover of Rs 879 crore in FY 16".

Orchid Pharma Limited has informed the Exchange regarding a press release dated March 17, 2016 titled "Orchid receives final USFDA nod for Rasagiline generic formulation".

Orchid Pharma Limited has informed the Exchange regarding a press release dated February 10, 2016 titled "Orchid Pharma registers turnover of Rs 204 crore in Q3 FY16, EBITDA of Rs 39 Crore".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange titled "Orchid Pharma registers turnover of Rs 211 crore in Q2 FY16, EBITDA of Rs 43 crore."

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 13, 2015 titled "Orchid Pharma registers turnover of Rs. 256 crore in Q1 FY16, EBITDA of Rs. 59 crore".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 28, 2015 titled "Orchid Pharma registers turnover of Rs. 1753 crore in FY15".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release with respect to Financial Results for the Quarter ended September 30, 2014 (Q4 FY15).

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Implementation of the CDR package Company consummates the business transfer agreement with Hospira

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding a Press Release dated June 19, 2014 titled "Orchid receives US FDA approval for Eszopiclone Tablets ANDA".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors at its meeting held on March 14,2014 has accepted the Letter of Approval (LOA) dated March 10, 2014 issued by Corporate Debt Restructuring Empowered Group (CDR EG) approving the Corporate Debt Restructuring proposal submitted by the Company.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Press Release dated February 11, 2014 titled "Orchid Pharma registers turnover of Rs. 372 crore in Q1 FY14, an increase of 19% YoY, EBITDA of Rs. 109 Cr. and EBIT of Rs. 52 Cr."

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange vide letter dated June 21, 2013 regarding "Reference to CDR Cell (Corporate Debt Restructuring Scheme)".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Press Release dated May 15, 2013 titled "Orchid Pharma registers turnover od Rs.268 crores in Q4 FY13"

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 18, 2013 titled "Orchid enters into strategic partnership with Allecra Therapeutics for development of noval antibiotics".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 13, 2013, titled "Orchid Pharma registers turnover of Rs 322 crore in Q3 FY13".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 09, 2012, titled "Orchid Pharma registers sale of Rs 330 crore in Q2 FY13".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 09, 2012, titled "Orchid Pharma to exit its Chinese JV".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a media release dated August 29, 2012, titled "Orchid Pharma enters into agreement to transfer its Penicillin & Penem API business & its API facilities in Aurangabad to Hospira for approximately US$ 200 million".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 14, 2012, titled "Orchid pharma registers a turnover of Rs 407 crore in Q1 FY13".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 14, 2012, titled "Orchid Pharma registers 6% growth in FY12".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 02, 2012, titled "Orchid Pharma receives US FDA approval for Naratriptan Tabs ANDA".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 25, 2012, titled "Orchid Pharma receives US FDA approval for Olanzapine Tabs ANDA".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 28, 2012, titled "Orchid redeems Foreign Currency Convertible Bonds (FCCBs) due in February 2012".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 08, 2012 titled "Orchid Pharma's strong growth trajectory continues in Q3 FY12".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 02, 2012, titled "Orchid Pharma receives US FDA approval for Levofloxacin Tabs ANDA".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 02, 2012, titled "Orchid Pharma reports successful completion of Phase-I study of its novel PDE4 inhibitor molecule, OCID 2987"

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 20, 2011, titled "Orchid's drug discovery research initiative with Merck advances Anti-infective program meets preclinical milestone".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 19, 2011, titled "Orchid Pharma ties up funds for FCCB redemption".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 01, 2011, titled "Orchid Pharma registers strong performance in Q2/H1 FY12; Net profit of Rs. 23 crore in Q2 FY12".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 16, 2011, titled "Orchid resumes production in its API plant in Chennai".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 29, 2011, titled "Orchid registers strong turnover of Rs 383.59 crore in Q1 FY12".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 14, 2011, titled "Orchid receives US FDA approval for Venlafaxine ER Capsules ANDA".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated June 22, 2011, titled "Orchid's state-of-the-art Cephalosporin API manufacturing facility successfully re-inspected by the USFDA".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated May 18, 2011, titled "Orchid Pharma achieves step function increase in performance in FY11; Consolidated topline soars to Rs 1786 crore in FY11; PAT stood at Rs 156 crore in FY11".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated January 27, 2011, titled "Orchid Pharma CMD Mr. K Raghavendra Rao awarded the prestigious 'padma Shri' Award by the Government of India".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated January 19, 2011, titled "Orchid achieves robust increase in performance during Q3 FY11".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Media release dated January 10, 2011, titled "Orchid Pharma CMD conferred with Icon of the Year Award by ICWAI".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated November 04, 2010, titled "Orchid redeems Foreign Currency Convertible Bonds (FCCBs) due in November 2010".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated October 28, 2010, titled "Orchid registers strong topline growth of 21% during Q2 FY11".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated July 21, 2010 titled "Orchid registers turnover of Rs 331 crore during Q1 FY11"

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated June 10, 2010 titled "Orchid to acquire US-based marketing company Karalex Pharma, LLC."

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 27, 2010, titled "Orchid's consolidated turnover for FY10 increase to Rs. 1343 crore".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 05, 2010, titled "Orchid enters into an out-licensing and distribution alliance with Alvogen to market oral non-antibiotic formulations in the US".

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 29, 2010, titled "Orchid settles Litigation with Forest Laboratories for Memantine Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ORCHID_pr_29042010.ZIP target=NEW> For more details click here.</a>